These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22249142)

  • 1. Host-tumor interactions in nasopharyngeal carcinomas.
    Gourzones C; Barjon C; Busson P
    Semin Cancer Biol; 2012 Apr; 22(2):127-36. PubMed ID: 22249142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells.
    Mrizak D; Martin N; Barjon C; Jimenez-Pailhes AS; Mustapha R; Niki T; Guigay J; Pancré V; de Launoit Y; Busson P; Moralès O; Delhem N
    J Natl Cancer Inst; 2015 Jan; 107(1):363. PubMed ID: 25505237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.
    Lee PJ; Sui YH; Liu TT; Tsang NM; Huang CH; Lin TY; Chang KP; Liu SC
    J Exp Clin Cancer Res; 2022 Aug; 41(1):254. PubMed ID: 35986369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.
    Klibi J; Niki T; Riedel A; Pioche-Durieu C; Souquere S; Rubinstein E; Le Moulec S; Guigay J; Hirashima M; Guemira F; Adhikary D; Mautner J; Busson P
    Blood; 2009 Feb; 113(9):1957-66. PubMed ID: 19005181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of LOX-1
    Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
    Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.
    Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC
    Front Immunol; 2021; 12():734293. PubMed ID: 34956172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of tumour-associated macrophages and regulatory T cells in EBV-positive and EBV-negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Sanders ME; Kranendonk M; Hofland I; de Bree R; Koljenović S; Willems SM
    J Clin Pathol; 2018 Mar; 71(3):267-274. PubMed ID: 28877959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.
    Paramita DK; Fatmawati C; Juwana H; van Schaijk FG; Fachiroh J; Haryana SM; Middeldorp JM
    J Med Virol; 2011 Apr; 83(4):665-78. PubMed ID: 21328382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
    Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
    Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus.
    Raab-Traub N
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):339-63. PubMed ID: 26424653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma.
    Renaud S; Lefebvre A; Mordon S; Moralès O; Delhem N
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells and EBV associated malignancies.
    Li J; Qian CN; Zeng YX
    Int Immunopharmacol; 2009 May; 9(5):590-2. PubMed ID: 19539572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma.
    Zhao J; Guo C; Xiong F; Yu J; Ge J; Wang H; Liao Q; Zhou Y; Gong Q; Xiang B; Zhou M; Li X; Li G; Xiong W; Fang J; Zeng Z
    Cancer Lett; 2020 May; 477():131-143. PubMed ID: 32061950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.